Items where authors include "Burns, S.O."

Article

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Maccari, M.E. orcid.org/0000-0001-6488-7622, Wolkewitz, M., Schwab, C. et al. (125 more authors) (2023) Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. Journal of Allergy and Clinical Immunology, 152 (4). 984-996.E10. ISSN 0091-6749

Hurst, J.R., Abbas, S.H., Bintalib, H.M. et al. (27 more authors) (2021) Granulomatous–lymphocytic interstitial lung disease : an international research prioritisation. ERJ Open Research, 7 (4). 00467-2021.

Tuijnenburg, P., Lango Allen, H., Burns, S.O. et al. (85 more authors) (2018) Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. Journal of Allergy and Clinical Immunology, 142 (4). pp. 1285-1296. ISSN 0091-6749

Lawless, D., Geier, C.B., Farmer, J.R. et al. (43 more authors) (2018) Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. Journal of Allergy and Clinical Immunology, 141 (6). pp. 2303-2306. ISSN 0091-6749

Maccari, M.E., Abolhassani, H., Aghamohammadi, A. et al. (64 more authors) (2018) Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry. Frontiers in Immunology, 9. 543. ISSN 1664-3224

Coulter, T.I., Chandra, A., Bacon, C.M. et al. (55 more authors) (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. Journal of Allergy and Clinical Immunology, 139 (2). 597-606.e4. ISSN 0091-6749